Bottles of a popular medication used to treat anxiety and panic disorders are being recalled nationwide, according to a report from the Food and Drug Administration.

One lot of Xanax, one of the most widely prescribed benzodiazepines, was recalled March 17 by pharmaceutical company Viatris because the drug failed to meet dissolution specifications. According to the FDA, the voluntary recall was listed as a “Class II” recall, which means temporary, adverse health consequences are possible.

According to health officials, drugs that don’t meet “dissolution specifications” could mean the pills aren’t as effective, or that they don’t release the correct dosage.

Lot number 8177156 was recalled, with bottles containing 60, 3mg extended-release tablets. The expiration date for the bottles was Feb. 28, 2027, the FDA said.

The pills were distributed nationwide between Aug. 27, 2024, and May 29, 2025, the California State Board of Pharmacy said. It wasn’t immediately clear how many bottles were recalled.

Vitaris Inc. did not immediately respond to NBC 5’s request for comment.